Related Experiment Video
Updated: Apr 20, 2026
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
Published on: January 12, 2022
High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2
Abstract:
Membranoproliferative glomerulonephritis (MPGN) type 2 is characterized by electron-dense deposits in the glomerular basement membrane and drusen-like deposits in Bruch's membrane. Over time, atrophic changes in the retina and retinal pigment epithelium occur, which can progress to choroidal neovascularization (CNV). This report describes a patient with MPGN type 2 who developed progressive loss of vision secondary to CNV. High-speed ultrahigh-resolution optical coherence tomography (UHR-OCT) showed an irregular Bruch's membrane that measured 10 μm beneath the foveal center. High-speed UHR-OCT can potentially be used to analyze Bruch's membrane in secondary ocular manifestations of diseases such as MPGN type 2 and primary retinal diseases such as age-related macular degeneration.
Insights
Membranoproliferative glomerulonephritis (MPGN) type 2 can cause vision loss due to choroidal neovascularization (CNV). High-speed ultrahigh-resolution OCT imaging aids in analyzing Bruch's membrane changes in MPGN type 2.
Area of Science:
- Ophthalmology
- Nephrology
- Medical Imaging
Background:
- Membranoproliferative glomerulonephritis (MPGN) type 2 is linked to electron-dense deposits in glomerular and Bruch's membranes.
- Progressive retinal and retinal pigment epithelium atrophy can lead to choroidal neovascularization (CNV).
Observation:
- A patient with MPGN type 2 experienced progressive vision loss due to CNV.
- High-speed ultrahigh-resolution optical coherence tomography (UHR-OCT) revealed an irregular Bruch's membrane (10 μm thick at the foveal center).
Findings:
- MPGN type 2 can manifest with secondary CNV and vision impairment.
- UHR-OCT effectively visualizes structural changes in Bruch's membrane.
Implications:
- High-speed UHR-OCT may be valuable for monitoring ocular complications in MPGN type 2.
- This imaging technique could also benefit patients with primary retinal diseases like age-related macular degeneration.
